Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.48
+0.30 (1.42%)
At close: Dec 31, 2025, 4:00 PM EST
21.48
0.00 (0.00%)
After-hours: Dec 31, 2025, 7:58 PM EST
Immunome Market Cap
Immunome has a market cap or net worth of $1.97 billion as of December 31, 2025. Its market cap has increased by 141.48% in one year.
Market Cap
1.97B
Enterprise Value
1.70B
1-Year Change
141.48%
Ranking
Category
Stock Price
$21.48
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $1.97B, an increase of 1,668.49%. That is a compound annual growth rate of 72.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.94B | 193.03% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |